Literature DB >> 30624199

Neutrophil:Lymphocyte Ratio as a Predictive Factor for Success of Nephron-Sparing Procedures in Patients with Emphysematous Pyelonephritis.

Chirag Punatar1, Kunal Jadhav1, Vikash Kumar1, Vinod Joshi1, Sharad Sagade1.   

Abstract

INTRODUCTION: We studied the value of neutrophil:lymphocyte ratio (NLR) in predicting the success of nephron-sparing procedures in management of emphysematous pyelonephritis.
METHODS: In this single-center retrospective study, patients underwent nephron-sparing procedures between 2007 and 2014. Severity was graded by Huang-Tseng classification. Thrombocytopenia, acute renal failure (ARF), shock, altered sensorium, and admission NLR were evaluated for predictive value for successful outcomes. Receiver operating characteristic curves were plotted to determine optimal cutoff of NLR for differentiating successful and unsuccessful outcomes. Two-sided p values were calculated with the χ2 test. Factors that were significant on univariate analysis were combined in a model with NLR.
RESULTS: Sixteen patients, 14 (87.5%) of whom were female and 14 (87.5%) of whom had diabetes, were included. Ten (63%) had severe emphysematous pyelonephritis. The optimal cutoff of NLR was 5. Four (44%) of 9 patients with NLR above 5 had unfavorable outcomes compared with none of 7 with NLR of 5 or less, giving a risk ratio of 1.8 (95% confidence interval [CI]= 1.01-3.22, p = 0.0417). Area under the curve for NLR alone was 0.77 (95% CI = 0.55-0.99, p = 0.014). High NLR and ARF were the only factors predicting unsuccessful outcome (p = 0.0417 each). When these were combined in a model (NLR as continuous variable), the area under the curve increased to 0.92.
CONCLUSION: NLR is a useful predictive marker in emphysematous pyelonephritis. Its predictive value increases when combined with presence or absence of ARF. In patients with high NLR and ARF, the threshold for considering nephrectomy should be low.

Entities:  

Mesh:

Year:  2019        PMID: 30624199      PMCID: PMC6326564          DOI: 10.7812/TPP/18-044

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  14 in total

1.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.

Authors:  J J Huang; C C Tseng
Journal:  Arch Intern Med       Date:  2000-03-27

3.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

Authors:  R Zahorec
Journal:  Bratisl Lek Listy       Date:  2001       Impact factor: 1.278

4.  Percutaneous management of emphysematous pyelonephritis.

Authors:  J Corr; M Gleeson; G Wilson; R Grainger
Journal:  Br J Urol       Date:  1993-04

5.  [Emphysematous pyelonephritis. Epidemiological, clinical, biological, bacteriological, radiological, therapeutic and prognostic features. Retrospective study of 30 cases].

Authors:  Mohamed Cherif; Walid Kerkeni; Abderrazak Bouzouita; Mohamed Slim Selmi; Amine Derouiche; Mohamed Riadh Ben Slama; Mohamed Chebil
Journal:  Tunis Med       Date:  2012-10

6.  Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis.

Authors:  Rakesh Kapoor; Kaliyaperumal Muruganandham; Anil Kumar Gulia; Manish Singla; Saurabh Agrawal; Anil Mandhani; M S Ansari; Aneesh Srivastava
Journal:  BJU Int       Date:  2009-11-20       Impact factor: 5.588

7.  Percutaneous management of localized emphysematous pyelonephritis.

Authors:  R J Zagoria; R B Dyer; L H Harrison; P L Adams
Journal:  J Vasc Interv Radiol       Date:  1991-02       Impact factor: 3.464

8.  Emphysematous pyelonephritis in diabetic patients.

Authors:  A R Pontin; R D Barnes; J Joffe; D Kahn
Journal:  Br J Urol       Date:  1995-01

9.  Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit.

Authors:  Cornelis P C de Jager; Paul T L van Wijk; Rejiv B Mathoera; Jacqueline de Jongh-Leuvenink; Tom van der Poll; Peter C Wever
Journal:  Crit Care       Date:  2010-10-29       Impact factor: 9.097

10.  Clinical profile and outcome of conservatively managed emphysematous pyelonephritis.

Authors:  Praveen Kumar Kolla; Desai Madhav; Satish Reddy; Suneetha Pentyala; Panil Kumar; Rama Mohan Pathapati
Journal:  ISRN Urol       Date:  2012-03-18
View more
  3 in total

1.  Coexistence of emphysematous cystitis and bilateral emphysematous pyelonephritis: a case report and review of the literature.

Authors:  Venice Chávez-Valencia; Citlalli Orizaga-de-La-Cruz; Omar Aguilar-Bixano; Francisco Alejandro Lagunas-Rangel
Journal:  CEN Case Rep       Date:  2020-04-23

Review 2.  Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Authors:  Xuan Thai Ngo; Tuan Thanh Nguyen; Ryan W Dobbs; Minh Sam Thai; Duc Huy Vu; Le Quy Van Dinh; Khoa Quy; Hieu Trong Le; Tien-Dat Hoang; Hanh Thi Tuyet Ngo; Trinh Ngoc Khanh Van; Ho Yee Tiong; Huy Gia Vuong
Journal:  World J Surg       Date:  2022-07-08       Impact factor: 3.282

3.  Culture-Negative Emphysematous Pyelonephritis as a Complication of Uncontrolled Diabetes Mellitus: A Case Report.

Authors:  Deborah Omoleye; Muhammad A Israr; Faria Tazin; Salma Habib; Shreeya Desai; Camille Celeste Go; Ayobami Aranmolate; Odalys Frontela
Journal:  Cureus       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.